Cargando…

Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts

Urothelial carcinoma of the bladder (UCB) and upper tracts (UTUC) is often regarded as one entity and is managed generally with similar principles. While neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is an established standard of care in UCB, strong evidence for a similar approa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tse, Jennifer, Ghandour, Rashed, Singla, Nirmish, Lotan, Yair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413224/ https://www.ncbi.nlm.nih.gov/pubmed/30781730 http://dx.doi.org/10.3390/ijms20040793

Ejemplares similares

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
por: D’Andrea, David, et al.
Publicado: (2020)

Evaluation of Hematuria in a Large Public Health Care System
por: Ghandour, Rashed, et al.
Publicado: (2019)

Neoadjuvant chemotherapy for upper tract urothelial carcinoma
por: Kim, Do Kyung, et al.
Publicado: (2020)

Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2020)

Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
por: Pradere, Benjamin, et al.
Publicado: (2020)

Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
por: Sheu, Zai-Lin, et al.
Publicado: (2022)

Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer
por: D’Andrea, David, et al.
Publicado: (2020)

Editorial: Prognostic research and precision oncology in upper tract urothelial carcinoma-volume II
por: Yang, Tsung-Mu, et al.
Publicado: (2023)

AB063. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2016)

The Significance of Preoperative Serum Sodium and Hemoglobin in Outcomes of Upper Tract Urothelial Carcinoma: Multi-Center Analysis Between China and the United States
por: Fang, Dong, et al.
Publicado: (2020)

Prognostic Factors for Contralateral Recurrence of Upper Tract Urothelial Carcinoma after Nephroureterectomy: A Large Multiregional Study
por: Chien, Tsu-Ming, et al.
Publicado: (2021)

Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation
por: Zhang, Lei, et al.
Publicado: (2015)

Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a pooled analysis
por: Qiu, Dongxu, et al.
Publicado: (2020)

Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: A nationwide cohort study
por: Tae, Jong Hyun, et al.
Publicado: (2022)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

The Role of Chemotherapy in Upper Tract Urothelial Carcinoma
por: O'Donnell, Peter H., et al.
Publicado: (2009)

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma
por: Fang, Dong, et al.
Publicado: (2018)

Two cycles of neoadjuvant chemotherapy improves survival in patients with high‐risk upper tract urothelial carcinoma
por: Zennami, Kenji, et al.
Publicado: (2020)

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study
por: Kubota, Yuka, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy before Nephroureterectomy in High-Risk Upper Tract Urothelial Cancer: A Systematic Review and Meta-Analysis
por: Oswald, David, et al.
Publicado: (2022)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
por: Meireles, Sara, et al.
Publicado: (2023)

Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
por: Ryoo, Hyunsoo, et al.
Publicado: (2021)

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study
por: Hamaya, Tomoko, et al.
Publicado: (2021)

Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report
por: Ikarashi, Daiki, et al.
Publicado: (2020)

Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
por: Kaag, Matthew G.
Publicado: (2020)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison
por: Sanford, Thomas, et al.
Publicado: (2015)

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Kim, Hongsik, et al.
Publicado: (2023)

Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review
por: Giudici, Nicola, et al.
Publicado: (2021)

Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2022)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

The Efficacy of Adjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Cell Carcinoma
por: Kim, Taek Sang, et al.
Publicado: (2013)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
por: Sung, Hyun Hwan, et al.
Publicado: (2022)

Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer
por: Yao, Lin, et al.
Publicado: (2016)

Management of Upper Tract Urothelial Carcinoma
por: Smith, Norm D.
Publicado: (2009)

Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder
por: Wang, Yuding, et al.
Publicado: (2013)

Risk factors for upper tract urothelial recurrence following local excision of bladder cancer
por: Lin, Ning, et al.
Publicado: (2018)

Ureteritis cystica mimicking upper tract urothelial cancer in a patient with bladder cancer
por: Muraki, Peter H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o446j5podkdk4be6lc14659r2i